These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3913457)

  • 1. Ultrasound as a screening procedure for methotrexate-induced hepatic damage in severe psoriasis.
    Miller JA; Dodd H; Rustin MH; Lees WR; Levene GM; Kirby JD; Munro DD
    Br J Dermatol; 1985 Dec; 113(6):699-705. PubMed ID: 3913457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
    vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC
    Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver biopsies upsilon liver scans in methotrexate-treated patients with psoriasis.
    Geronemus RG; Auerbach R; Tobias H
    Arch Dermatol; 1982 Sep; 118(9):649-51. PubMed ID: 7114866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of liver ultrasound with liver biopsy histology in psoriatics receiving long-term methotrexate therapy.
    Coulson IH; Mckenzie J; Neild VS; Joseph AE; Marsden RA
    Br J Dermatol; 1987 Apr; 116(4):491-5. PubMed ID: 3555595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
    Zachariae H; Grunnet E; Sogaard H
    Acta Derm Venereol; 1975; 55(4):291-6. PubMed ID: 52258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB; Arnold GL; Gowans JD; Kaplan MM
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
    Kumar B; Saraswat A; Kaur I
    Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate maintenance therapy and liver damage in psoriasis.
    van de Kerkhof PC; Hoefnagels WH; van Haelst UJ; Mali JW
    Clin Exp Dermatol; 1985 May; 10(3):194-200. PubMed ID: 4006282
    [No Abstract]   [Full Text] [Related]  

  • 9. [Liver biopsy studies in long-term therapy of psoriasis using methotrexate].
    Dietz O; Pachaly A; Schillat I
    Dermatol Monatsschr; 1974 Aug; 160(8):634-42. PubMed ID: 4216519
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Palmer HM
    Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
    [No Abstract]   [Full Text] [Related]  

  • 11. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.
    Chalmers RJ; Kirby B; Smith A; Burrows P; Little R; Horan M; Hextall JM; Smith CH; Klaber M; Rogers S
    Br J Dermatol; 2005 Mar; 152(3):444-50. PubMed ID: 15787812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens.
    Berends MA; van Oijen MG; Snoek J; van de Kerkhof PC; Drenth JP; Han van Krieken J; de Jong EM
    Arch Dermatol; 2007 Dec; 143(12):1515-9. PubMed ID: 18087000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in liver histology during methotrexate therapy of psoriasis correlated to the concentration of methotrexate and folate in erythrocytes.
    Hendel J; Poulsen H; Nyfors B; Nyfors A
    Acta Pharmacol Toxicol (Copenh); 1985 Apr; 56(4):321-6. PubMed ID: 4024960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of liver function using fasting bile salt concentrations in psoriasis prior to and during methotrexate therapy.
    Lawrence CM; Strange RC; Summerly R; Scriven AJ; Elmahallawy M; Wood A; Fletcher PJ; Beckett GJ
    Clin Chim Acta; 1983 Apr; 129(3):341-51. PubMed ID: 6851172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver biopsies in psoriatics--complications and evaluation.
    Creswell SN; Burrows D
    Int J Dermatol; 1980 May; 19(4):217-9. PubMed ID: 7399795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of antipyrine clearance to measure liver damage in psoriatic patients receiving methotrexate.
    Paramsothy J; Strange R; Sharif H; Collins M; Shaw P; Lawrence CM
    Br J Dermatol; 1988 Dec; 119(6):761-5. PubMed ID: 3203069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver damage due to methotrexate in patients with psoriasis.
    Dahl MG; Gregory MM; Scheuer PJ
    Br Med J; 1971 Mar; 1(5750):625-30. PubMed ID: 5548839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver biopsy versus ultrasound in methotrexate-treated psoriasis: a decision analysis.
    Verschuur AC; van Everdingen JJ; Cohen EB; Chamuleau RA
    Int J Dermatol; 1992 Jun; 31(6):404-9. PubMed ID: 1512092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.
    Boffa MJ; Smith A; Chalmers RJ; Mitchell DM; Rowan B; Warnes TW; Shomaf M; Haboubi NY
    Br J Dermatol; 1996 Oct; 135(4):538-44. PubMed ID: 8915142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.